CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-14 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion | +7,809 | 111,983 | ||
| 2020-02-14 | Stelzer Laurie SVP, Chief Financial Officer | Shares withheld for taxes | −2,700 | $21.10 | $57K | 109,283 |
| 2020-02-14 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,809 | 15,616 | ||
| 2020-02-14 | Torley Helen President and CEO | Exercise or conversion | +28,730 | 484,923 | ||
| 2020-02-14 | Torley Helen President and CEO | Shares withheld for taxes | −14,244 | $21.10 | $301K | 470,679 |
| 2020-02-14 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −28,730 | 57,458 | ||
| 2020-02-12 | Matsuda Masaru SVP, General Counsel | Exercise or conversion | +4,130 | 8,619 | ||
| 2020-02-12 | Matsuda Masaru SVP, General Counsel | Shares withheld for taxes | −1,681 | $20.00 | $34K | 6,938 |
| 2020-02-12 | Matsuda Masaru SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −4,130 | 12,387 | ||
| 2020-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +7,883 | 169,376 | ||
| 2020-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −2,725 | $20.00 | $55K | 166,651 |
| 2020-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −7,883 | 23,649 | ||
| 2020-02-12 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion | +11,262 | 108,068 | ||
| 2020-02-12 | Stelzer Laurie SVP, Chief Financial Officer | Shares withheld for taxes | −3,894 | $20.00 | $78K | 104,174 |
| 2020-02-12 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −11,262 | 0 | ||
| 2020-02-12 | Torley Helen President and CEO | Exercise or conversion | +32,795 | 472,452 | ||
| 2020-02-12 | Torley Helen President and CEO | Shares withheld for taxes | −16,259 | $20.00 | $325K | 456,193 |
| 2020-02-12 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −32,795 | 98,384 | ||
| 2020-02-10 | Matsuda Masaru SVP, General Counsel | Grant or award · Option to Purchase Common Stock | +53,211 | 53,211 | ||
| 2020-02-10 | Matsuda Masaru SVP, General Counsel | Grant or award · Restricted Stock Units | +25,026 | 25,026 |
Page 57 of 59 · 1,177 trades